Extramural Funding & Training Opportunities

Posted Date: Jan 17, 2019

Application Due Date: 
Feb 20, 2019, by 5:00 PM local time of applicant organization

This FOA will expire on Feb 21, 2019.

Administrative Supplement for Research on Sex/Gender Influences

PA-19-165

This Funding Opportunity Announcement (FOA) requests applications for one year of funding for the fiscal year (FY) 2019 Administrative Supplements for Research on Sex/Gender Influences. This program is designed to provide supplemental funding to NIH-funded researchers to encourage the consideration of sex/gender factors in their ongoing research. The proposed research must address at least one of the five strategic goals of the new 2019-2023 Trans-NIH Strategic Plan for the Health of Women "Advancing Science for the Health of Women."

To access the application and additional information, please visit: 

https://grants.nih.gov/grants/guide/pa-files/PA-19-165.html

Posted Date: Dec 21, 2018

Standard dates apply by 5:00 PM local time of applicant organization

This FOA will expire on Jan 8, 2022

End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses

R21 Clinical Trial Optional: PAR-19-153

R01 Clinical Trial Optional: PAR-19-136

The purpose of this funding opportunity announcement (FOA) is to foster research on the unique perspectives, needs, wishes, and decision-making processes of adolescents and young adults (AYA; defined by the World Health Organization and the Centers for Disease Control and Prevention as youth between 12 – 24 years of age) with serious, advanced illnesses; and research focused on specific end-of-life/palliative care (EOLPC) models that support the physical, psychological, spiritual, and social needs of AYA with serious illness, their families and caregivers.

To access the application and additional information, please visit:

R21:https://grants.nih.gov/grants/guide/pa-files/PAR-19-153.html

R01:https://grants.nih.gov/grants/guide/pa-files/PAR-19-136.html

Posted Date: Dec 10, 2018

Application Due Date:  Mar 15, 2019 by 5pm local time of applicant organization

Letter of Intent due 30 days prior to the application due date

This RFA will expire on Mar 16, 2019.

HEAL Initiative: Pragmatic Randomized Controlled Trial of Acupuncture for Management of Chronic Low Back Pain in Older Adults

UG3/UH3 Clinical Trial Required: RFA-AT-19-005

This Funding Opportunity Announcement (FOA) encourages UG3/UH3 phased cooperative research applications to conduct an efficient, large-scale pragmatic trial to evaluate the impact of, and strategies to best implement, acupuncture treatment of older adults (65 years and older) with chronic low back pain.  This FOA requires that the intervention under study be embedded into health care delivery system, “real world” settings.  Awards made under this FOA will initially support a one-year milestone-driven planning phase (UG3), with possible transition to an implementation phase (UH3). UG3 projects that have met the scientific milestone and feasibility requirements may transition to the three-year UH3 phase. The UG3/UH3 application must be submitted as a single application, following the instructions described in this FOA.

Trials must be conducted across two or more health care systems (HCS) and will become part of and work with the NIH HCS Research Collaboratory, which is supported through the NIH Common Fund (See https://commonfund.nih.gov/hcscollaboratory).

To access the application and additional information, please visit: https://grants.nih.gov/grants/guide/rfa-files/RFA-AT-19-005.html

Posted Date: Nov 26, 2018

Application Due Date: 
Feb 26, 2019 by 5:00 PM local time of applicant organization

Alzheimer's-focused administrative supplements for NIH grants that are not focused on Alzheimer's disease

Notice Number: NOT-AG-18-039

- Purpose is to expand existing awards that are not currently focused on Alzheimer’s disease and its related dementias (ADRD) to allow them to develop a focus on ADRD

- Active awards with project end dates in FY 2020 or later are eligible. The award may not be in terminal no cost extension or going into no cost extension in FY2019

One year of support; Budget limited to no more than $250,000 in direct costs but may not exceed the amount of the current annual budget of the parent award

- Proposed work must be within the scope of the current project

- Proposed work must have relevance to Alzheimer’s disease or a related dementia

You are encouraged to contact both your NINR Program Officer and Lois Tully (lois.tully@nih.gov) to discuss your proposed research.

To access additional information, please visit: https://grants.nih.gov/grants/guide/notice-files/NOT-AG-18-039.html

Posted Date: Nov 7, 2018

Standard dates apply, by 5:00 PM local time of applicant organization

This FOA will expire on Jan 8, 2022.

Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals 

R21 Clinical Trial Optional: PAR-19-058

R01 Clinical Trial Optional: PAR-19-057

The purpose of this funding opportunity announcement (FOA) is to encourage research that will improve and increase the use of evidence-based interventions in end-of-life and palliative care (EOLPC) for American Indian/Alaska Native (AI/AN) individuals with advanced illness and their families and communities.

To access the application and additional information, please visit:

R21:https://grants.nih.gov/grants/guide/pa-files/PAR-19-058.html

R01:https://grants.nih.gov/grants/guide/pa-files/PAR-19-057.html

Posted Date: Nov 7, 2018

Standard dates apply, by 5:00 PM local time of applicant organization.

Letter of Intent due 30 days prior to the application due date

This FOA will expire on Jan 8, 2022.

NINR Clinical Trial Planning Grant

R34 Clinical Trial Required: PAR-19-060

The purpose of this Funding Opportunity Announcement (FOA) is to provide time and support for the applicant to develop and finalize plans for the design and execution of investigator-initiated clinical trials that are highly relevant to the NINR mission. Activities supported by this planning grant must include feasibility and pilot studies that inform the intervention viability and/or the trial design.

To access the application and additional information, please visit: https://grants.nih.gov/grants/guide/pa-files/PAR-19-060.html

Posted Date: Oct 31, 2018

Standard dates apply, by 5:00 PM local time of applicant organization

This FOA will expire on Jan 8, 2022.

End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms

R21 Clinical Trial Optional: PAR-19-044

R01 Clinical Trial Optional: PAR-19-045

The purpose of this funding opportunity announcement (FOA) is to stimulate research to examine the multi-dimensional foundations, experiences, and management of complex, advanced signs and symptoms at the end of life.

To access the application and additional information, please visit:

R21: https://grants.nih.gov/grants/guide/pa-files/PAR-19-044.html

R01: https://grants.nih.gov/grants/guide/pa-files/PAR-19-045.html

Posted Date: Jan 24, 2018

Application Due Dates: March 27, 2018; February 20, 2019; and February 20, 2020, by 5:00 PM local time of applicant organization

Letter of Intent due 30 days prior to the application due date

This FOA will expire on February 21, 2020.

Pragmatic Trials for Dementia Care in Long-term Services and Support (LTSS) Settings 

R61/R33 Clinical Trial Required: PAR-18-585

This FOA invites applications for pragmatic trials for dementia care in Long-term Services and Support (LTSS) settings which will: (1) be designed to address practical comparative questions faced by Alzheimer’s disease (AD) and AD-related dementia (ADRD) patients, clinicians and caregivers (both paid and unpaid); (2) include broad and diverse populations; and (3) be conducted in real-world settings. These trials are intended to produce results that can be directly adopted by healthcare providers, patients or caregivers for rapid translation. Successful applications will: (1) improve quality of care of persons with dementia; (2) improve quality of life for persons with dementia and their informal caregivers; (3) deliver more patient-focused, cost-effective care in LTSS; and/or (4) reduce disparities in LTSS care.

To access the application and additional information, please visit: https://grants.nih.gov/grants/guide/pa-files/PAR-18-585.html

Posted Date: Dec 15, 2017

Standard dates apply, by 5PM local time

This FOA will expire on May 8, 2021.

End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness  

R21 Clinical Trial Optional: PA-18-499

R01 Clinical Trial Optional: PA-18-498

This funding opportunity announcement (FOA) seeks to stimulate research focused on identification of the key barriers to effective end-of-life and palliative care (EOLPC) health literacy in diverse settings and populations, and to create novel strategies, interventions, and models of care to improve EOLPC health literacy, with the goal of improving outcomes for individuals with serious, advanced illness and their families and caregivers.

To access the application and additional information, please visit:

R21: https://grants.nih.gov/grants/guide/pa-files/PA-18-498.html

R01: https://grants.nih.gov/grants/guide/pa-files/PA-18-499.html

Posted Date: Jan 8, 2019

Standard dates apply by 5:00 PM local time of applicant organization

Letter of Intent Due 30 days prior to the application due date

This FOA will expire on Jan 8, 2021

NHLBI Clinical Trial Pilot Studies

R34 Clinical Trial Optional: PAR-19-155

This Funding Opportunity Announcement (FOA) is to support studies that are scientifically essential, yet also sufficient, for investigators to make definitive decisions that inform the final designs of important Phase II and beyond clinical trials within NHLBI's mission; that is, clinical trials with the primary intent of testing the efficacy, safety, clinical management, or implementation of intervention(s) in the prevention and treatment of heart, lung, blood, and sleep disorders. This mechanism may be used to test the feasibility of novel and efficient (pragmatic) trial designs, as well as determine the feasibility of an intervention, intervention parameters, subject availability, or other information essential to complete the design of a trial. Applications should demonstrate that the proposed studies are both necessary and sufficient to permit definitive decisions about the final design of the subsequent clinical trial.

To access the application and additional information, please visit: https://grants.nih.gov/grants/guide/pa-files/PAR-19-155.html

Posted Date Nov 30, 2017

Application Due Dates: June 11, 2018;  October 8, 2018; June 10, 2019, by 5PM local time of applicant organization

This FOA will expire June 11, 2019.

Building Evidence: Effective Palliative/End of Life Care Interventions

R01 Clinical Trial Optional: PAR-18-173

This funding opportunity announcement (FOA) seeks to stimulate research that tests optimal end-of-life and palliative care (EOLPC) interventions/models of care that are based on individual- and family-centered outcomes. The testing of EOLPC interventions and models of care are urgently needed that address racial, ethnic and/or cultural diversity in children and adults for those with serious, advanced illness. Trials are needed to test efficacy and effectiveness of these interventions and/or models of care.

To access the application and additional information, please visit: https://grants.nih.gov/grants/guide/pa-files/PAR-18-173.html

Posted Date: Nov 28, 2017

Application Due Dates: April 11, 2018; October 10, 2018, April 11, 2019, by 5:00 PM local time of applicant organization

Letter of Intent Due Date: 30 days before application due date

This FOA will expire April 12, 2019

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization

R21 Clinical Trial Optional: PAR-18-247

R01 Clinical Trial Optional: PAR-18-246

This Funding Opportunity Announcement (FOA) invites applications for intervention research designed to support caregivers of adult cancer patients. Interventions supported by this FOA are intended to provide caregivers with care training, promote coping skills, and ultimately help them manage care. Outcomes of such interventions are expected to (1) optimize patient health care utilization, (2) improve caregiver well-being, and (3) improve patient physical health and psychosocial outcomes.

To access the application and additional information, please visit:

R21: https://grants.nih.gov/grants/guide/pa-files/PAR-18-247.html

R01: https://grants.nih.gov/grants/guide/pa-files/PAR-18-246.html

Posted Date: Nov 8, 2017

Standard dates apply, by 5:00 PM local time of applicant organization.

This FOA will expire on May 8, 2020

Promoting Caregiver Health Using Self-Management

R01 Clinical Trial Optional: PA-18-150

The purpose of this initiative is to stimulate research in promoting caregiver health using self-management.  Caregiving is an important science area since the number of people living longer with chronic conditions is growing.  Informal caregivers (lay caregivers) are defined as unpaid individuals (spouses, partners, family members, friends, or neighbors) involved in assisting others with activities of daily living and/or medical tasks.  Formal caregivers are paid, delivering care in one’s home or care settings (daycare, residential care facility).  This concept focuses on informal caregivers.

To access the application and additional information, please visit:  https://grants.nih.gov/grants/guide/pa-files/PA-18-150.html

Posted Date: Nov 7, 2017

Standard dates apply, by 5:00 PM local time

This FOA will expire on Jan 8, 2020.

Improving Individual and Family Outcomes through Continuity and Coordination of Care in Hospice

R21 Clinical Trial Optional: PA-18-166

R01 Clinical Trial Optional: PA-18-148

This funding opportunity announcement (FOA) seeks to stimulate research that focuses on reducing negative individual and family outcomes related to unwanted transitions at the end of life and optimizing the individual and family outcomes related to high quality coordination of care of care of individuals who are enrolled in hospice. This FOA emphasizes individuals who are receiving hospice care and their family caregivers, in any setting where hospice care is provided, including their home, a relative’s home, a hospice inpatient facility, an assisted living facility, a short- or long-term care facility, or a hospital.

To access the application and additional information, please visit:

R21: https://grants.nih.gov/grants/guide/pa-files/PA-18-166.html

R01: https://grants.nih.gov/grants/guide/pa-files/PA-18-148.html

Posted Date: Nov 7, 2017

Standard dates apply, by 5:00 PM local time of applicant organization.

This FOA will expire on Jan 8, 2020

Palliative Care Needs of Individuals with Rare Advanced Diseases and Their Family Caregivers

R21 Clinical Trial Optional: PA-18-167

R01 Clinical Trial Optional: PA-18-149

This funding opportunity announcement (FOA) seeks to expand knowledge and increase the evidence base for palliative care (PC) in advanced rare diseases, including rare cancers, and to improve physical and psychosocial well-being and quality of life among seriously ill individuals and their family caregivers.

To access the application and additional information, please visit:

R21: https://grants.nih.gov/grants/guide/pa-files/PA-18-167.html

R01: https://grants.nih.gov/grants/guide/pa-files/PA-18-149.html

Posted Date: Nov 3, 2017 (R21, R01); May 10, 2016 (R03)

Standard dates apply by 5:00 PM local time of applicant organization

Letter of Intent Due 30 days prior to the application due date

This FOA will expire on May 8, 2019

Dissemination and Implementation Research in Health

R21 Clinical Trial Optional: PAR-18-017

R01 Clinical Trial Optional: PAR-18-007

R03 Small Grant Program: PAR-16-237

This Funding Opportunity Announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, evaluate and refine effective and efficient methods, systems, infrastructures, and strategies to disseminate and implement evidence-based health behavior change interventions, evidence-based prevention, early detection, diagnostic, treatment and management, and quality of life improvement services into public health, clinical practice, and community settings.

To access the application and additional information, please visit:

R21: https://grants.nih.gov/grants/guide/pa-files/PAR-18-017.html

R01:https://grants.nih.gov/grants/guide/pa-files/PAR-18-007.html

R03: https://grants.nih.gov/grants/guide/pa-files/PAR-16-237.html

Application Due Date: February 1^st of desired start year

Candidates will be selected on a rolling basis each year until each of the two new slots per year are filled.

This 2-year Postdoctoral Training Program in Behavioral Geriatrics develops independent investigators capable of conducting patient-oriented research to improve the quality of life and quality of care of older adults. The  Program is co-led by Cary Reid, MD, PhD, Director of the Translational Research Institute on Pain in Later Life and Holly G. Prigerson, PhD, Director of the Center for Research on End-of-Life Care both based in the Department of Medicine, Division of Geriatrics and Palliative Medicine at Weill Cornell Medicine. Applications are accepted from both MD and PhD postdoctoral trainees (2/year) seeking careers at the intersection of biomedical and innovative social/behavioral approaches to improve care and care outcomes in older adults.

Please see the links below for more information:

• Behavioral Geriatrics T32 Flyer
• T32 Program Information
• Translational Research Institute for Pain in Later Life (TRIPLL)
• Weill Cornell Medical Center for Research on End-of-Life Care

Application Due Date: January 21, 2019

Letter of Intent Due Date:
November 5, 2018

National Palliative Care Research Center (NPCRC): 

Pilot/Exploratory Project Grants (PEP) & Junior Faculty Career Development Awards (CDA)

These RFAs are limited to applications that focus on palliative care research projects for seriously ill patients and their families in one or more of the three specific areas:

1) Exploring the relationship of pain and other distressing symptoms to quality and quantity of life, independence, function, and disability and developing interventions directed at their treatment in patients with serious and chronic illnesses.

2) Studying methods of improving communication between patients living with serious illness, their families and their health care providers;

3) Evaluating models and systems of care for patients living with serious illness and their families.

Of note, research focused on advanced care planning will not be considered this year due to NPCRC current funding priorities.

For more information about the RFA and application process, please visit the NPCRC’s website at: www.npcrc.org.

Cambia Palliative Care Center of Excellence Palliative Care Research Fellowship Program

Fellowships will be 1-3 years in duration. Trainees must have an interest in palliative care research related to heart, lung or blood disease.

For more details and information about the Palliative Care Research Fellowship, please visit http://www.uwpalliativecarecenter.com
or email us at pallcntr@uw.edu